Skip to main content
. Author manuscript; available in PMC: 2023 Jan 26.
Published in final edited form as: Cancer. 2022 Oct 12;128(23):4119–4128. doi: 10.1002/cncr.34489

Table 1.

Distribution of breast cancer-related lymphedema (BCRL) following surgery among women with breast cancer (stage I-III) in the Carolina Breast Cancer Study (Phase 3, diagnosis years 2008-2013)

Time of Assessment
Characteristics Baseline
N=2645
Two-year follow-up
N=2273
Seven-year follow-up
N=1654
Cumulative cases of BCRL 180 477 552
Point prevalence of ever having BCRL, n (% of total population) 180 (6.8%) 452 (19.9%) 393 (23.8%)
Location;
n (%)a
Arm 159 (88.3%) 375 (90.1%) 298 (93.1%)
Trunk 43 (23.9%) 57 (13.7%) 44 (13.7%)
Breast 28 (15.6%) 112 (26.9%) 64 (20.0%)
Arm, trunk AND breast 7 (3.9%) 34 (8.2%) 16 (5.0%)
Dominant side 82 (45.6%) 209 (50.2%) 149 (46.6%)
Non-dominant side 100 (55.6%) 220 (52.9%) 187 (58.4%)
Diagnosis by provider;
n (%)b
Medical doctor 127 (70.6%) 303 (73.2%) 247 (77.2%)
Nurse 7 (3.9%) 27 (6.5%) 20 (6.2%)
Physical therapist 30 (16.7%) 145 (35.0%) 92 (28.7%)
Other 20 (11.1%) 21 (5.1%) 11 (3.4%)
Episodic nature;
n (%)c
Single episode 12 (6.7%) 70 (17.0%) 62 (19.6%)
Recurrent (comes and goes) 77 (42.8%) 155 (37.7%) 126 (39.7%)
Persistent 91 (50.6%) 186 (45.3%) 129 (40.7%)
a.

Participants could report BCRL in multiple body parts, therefore the percentages do not add up to 100%.

b.

Participants could respond yes to multiple diagnosis providers; therefore the percentages do not sum to 100%. 2 cases at the two-year follow-up did not respond to questions for diagnosis provider.

c.

5 cases at the two-year follow-up and 3 cases at the seven-year follow-up did not respond to questions for episodic nature.